| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.77e-09 | 46 | 51 | 6 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.78e-07 | 188 | 51 | 7 | GO:0005201 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SOX4 MSX1 RNASEL NFATC4 NFIX PIN1 EVX1 DLX1 ZFPM1 TAF10 FUBP3 NR2F1 EBF4 ZNF513 | 3.51e-06 | 1390 | 50 | 14 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of binding | 4.47e-05 | 396 | 50 | 7 | GO:0051098 | |
| GeneOntologyBiologicalProcess | negative regulation of binding | 5.63e-05 | 170 | 50 | 5 | GO:0051100 | |
| GeneOntologyCellularComponent | collagen trimer | 7.24e-08 | 88 | 51 | 6 | GO:0005581 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.52e-05 | 332 | 51 | 7 | GO:0005788 | |
| GeneOntologyCellularComponent | nuclear speck | 7.98e-05 | 431 | 51 | 7 | GO:0016607 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 8.70e-05 | 6 | 51 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | P-body | 1.12e-04 | 102 | 51 | 4 | GO:0000932 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.62e-04 | 8 | 51 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.62e-04 | 8 | 51 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.62e-04 | 8 | 51 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.74e-04 | 656 | 51 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.78e-04 | 658 | 51 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.85e-04 | 530 | 51 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | nuclear body | 2.99e-04 | 903 | 51 | 9 | GO:0016604 | |
| GeneOntologyCellularComponent | chromatin | 7.37e-04 | 1480 | 51 | 11 | GO:0000785 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.19e-03 | 21 | 51 | 2 | GO:0098644 | |
| GeneOntologyCellularComponent | COPI-coated vesicle | 2.94e-03 | 33 | 51 | 2 | GO:0030137 | |
| Domain | Collagen | 1.14e-07 | 85 | 51 | 6 | PF01391 | |
| Domain | Collagen | 1.14e-07 | 85 | 51 | 6 | IPR008160 | |
| Domain | Homeobox_metazoa | 1.06e-04 | 90 | 51 | 4 | IPR020479 | |
| Domain | C4 | 1.09e-04 | 6 | 51 | 2 | SM00111 | |
| Domain | - | 1.09e-04 | 6 | 51 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 1.09e-04 | 6 | 51 | 2 | IPR001442 | |
| Domain | NC1_IV | 1.09e-04 | 6 | 51 | 2 | PS51403 | |
| Domain | C4 | 1.09e-04 | 6 | 51 | 2 | PF01413 | |
| Domain | Laminin_G | 5.32e-04 | 58 | 51 | 3 | IPR001791 | |
| Domain | HTH_motif | 8.85e-04 | 69 | 51 | 3 | IPR000047 | |
| Domain | Homeobox_CS | 1.65e-03 | 186 | 51 | 4 | IPR017970 | |
| Domain | TSPN | 1.78e-03 | 23 | 51 | 2 | SM00210 | |
| Domain | IPT | 2.46e-03 | 27 | 51 | 2 | SM00429 | |
| Domain | RRM_1 | 2.48e-03 | 208 | 51 | 4 | PF00076 | |
| Domain | Ig_E-set | 2.88e-03 | 104 | 51 | 3 | IPR014756 | |
| Domain | RRM | 2.89e-03 | 217 | 51 | 4 | SM00360 | |
| Domain | TIG | 3.23e-03 | 31 | 51 | 2 | PF01833 | |
| Domain | RRM_dom | 3.40e-03 | 227 | 51 | 4 | IPR000504 | |
| Domain | Fibrinogen_a/b/g_C_dom | 3.44e-03 | 32 | 51 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 3.44e-03 | 32 | 51 | 2 | PS51406 | |
| Domain | IPT | 3.44e-03 | 32 | 51 | 2 | IPR002909 | |
| Domain | FIBRINOGEN_C_1 | 3.44e-03 | 32 | 51 | 2 | PS00514 | |
| Domain | RRM | 3.56e-03 | 230 | 51 | 4 | PS50102 | |
| Domain | Homeobox | 3.78e-03 | 234 | 51 | 4 | PF00046 | |
| Domain | HOMEOBOX_1 | 3.90e-03 | 236 | 51 | 4 | PS00027 | |
| Domain | HOX | 3.96e-03 | 237 | 51 | 4 | SM00389 | |
| Domain | Homeobox_dom | 4.08e-03 | 239 | 51 | 4 | IPR001356 | |
| Domain | HOMEOBOX_2 | 4.08e-03 | 239 | 51 | 4 | PS50071 | |
| Domain | - | 4.39e-03 | 244 | 51 | 4 | 3.30.70.330 | |
| Domain | KH_1 | 4.83e-03 | 38 | 51 | 2 | PF00013 | |
| Domain | - | 5.08e-03 | 39 | 51 | 2 | 3.30.1370.10 | |
| Domain | KH | 5.34e-03 | 40 | 51 | 2 | SM00322 | |
| Domain | KH_dom | 5.34e-03 | 40 | 51 | 2 | IPR004087 | |
| Domain | Nucleotide-bd_a/b_plait | 5.34e-03 | 258 | 51 | 4 | IPR012677 | |
| Domain | KH_TYPE_1 | 5.87e-03 | 42 | 51 | 2 | PS50084 | |
| Domain | KH_dom_type_1 | 6.43e-03 | 44 | 51 | 2 | IPR004088 | |
| Domain | - | 7.38e-03 | 283 | 51 | 4 | 1.10.10.60 | |
| Domain | VWA | 1.02e-02 | 56 | 51 | 2 | PF00092 | |
| Domain | - | 1.06e-02 | 57 | 51 | 2 | 3.30.50.10 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.13e-09 | 44 | 42 | 6 | M27812 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 4.21e-08 | 67 | 42 | 6 | M26999 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.27e-07 | 41 | 42 | 5 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.49e-07 | 90 | 42 | 6 | M631 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 9.66e-07 | 61 | 42 | 5 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.23e-06 | 64 | 42 | 5 | M26953 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.54e-06 | 74 | 42 | 5 | M160 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.90e-06 | 76 | 42 | 5 | MM14867 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.90e-06 | 76 | 42 | 5 | MM14573 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.05e-06 | 85 | 42 | 5 | M16441 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.01e-05 | 46 | 42 | 4 | M198 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.42e-05 | 50 | 42 | 4 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.79e-05 | 53 | 42 | 4 | MM14566 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.40e-05 | 57 | 42 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.57e-05 | 58 | 42 | 4 | M2049 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.62e-05 | 300 | 42 | 7 | M610 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 2.71e-05 | 20 | 42 | 3 | M15394 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.71e-05 | 20 | 42 | 3 | MM15061 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.14e-05 | 61 | 42 | 4 | M27103 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.57e-05 | 63 | 42 | 4 | M11187 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 4.18e-05 | 23 | 42 | 3 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 4.18e-05 | 23 | 42 | 3 | MM1427 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.29e-05 | 66 | 42 | 4 | M18 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.69e-05 | 140 | 42 | 5 | M587 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 7.47e-05 | 76 | 42 | 4 | M27219 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.07e-04 | 258 | 42 | 6 | MM14572 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.93e-04 | 38 | 42 | 3 | MM14969 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.60e-04 | 42 | 42 | 3 | M7169 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 2.79e-04 | 43 | 42 | 3 | M53 | |
| Pathway | REACTOME_OAS_ANTIVIRAL_RESPONSE | 3.08e-04 | 9 | 42 | 2 | M27859 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.58e-04 | 114 | 42 | 4 | MM14571 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 3.84e-04 | 10 | 42 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 3.84e-04 | 10 | 42 | 2 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 4.69e-04 | 11 | 42 | 2 | M15422 | |
| Pathway | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | 5.49e-04 | 54 | 42 | 3 | MM15089 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 5.61e-04 | 12 | 42 | 2 | MM15093 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 5.61e-04 | 12 | 42 | 2 | MM1526 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 5.61e-04 | 12 | 42 | 2 | M27352 | |
| Pathway | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | 6.11e-04 | 56 | 42 | 3 | M839 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 6.62e-04 | 13 | 42 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 6.62e-04 | 13 | 42 | 2 | M12950 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 6.66e-04 | 1022 | 42 | 10 | MM15436 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 7.71e-04 | 14 | 42 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 7.71e-04 | 14 | 42 | 2 | M6487 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 8.88e-04 | 15 | 42 | 2 | M27161 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 8.88e-04 | 15 | 42 | 2 | M12101 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 8.88e-04 | 15 | 42 | 2 | M1262 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 8.88e-04 | 15 | 42 | 2 | MM14922 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 8.88e-04 | 15 | 42 | 2 | MM14959 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 8.88e-04 | 15 | 42 | 2 | MM14961 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.02e-03 | 261 | 42 | 5 | MM15676 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.03e-03 | 151 | 42 | 4 | M550 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.29e-03 | 18 | 42 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.29e-03 | 18 | 42 | 2 | MM14882 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 1.43e-03 | 19 | 42 | 2 | M27423 | |
| Pathway | WP_FOCAL_ADHESION | 2.26e-03 | 187 | 42 | 4 | MM15913 | |
| Pathway | REACTOME_DEADENYLATION_OF_MRNA | 2.29e-03 | 24 | 42 | 2 | MM15090 | |
| Pathway | PID_MYC_PATHWAY | 2.49e-03 | 25 | 42 | 2 | M139 | |
| Pathway | REACTOME_DEADENYLATION_OF_MRNA | 2.49e-03 | 25 | 42 | 2 | M13492 | |
| Pathway | WP_FOCAL_ADHESION | 2.84e-03 | 199 | 42 | 4 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.84e-03 | 199 | 42 | 4 | M7253 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 2.90e-03 | 27 | 42 | 2 | M760 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 3.12e-03 | 28 | 42 | 2 | MM14958 | |
| Pathway | WP_PI3KAKT_SIGNALING | 3.20e-03 | 339 | 42 | 5 | M39736 | |
| Pathway | PID_EPHRINB_REV_PATHWAY | 3.58e-03 | 30 | 42 | 2 | M257 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.58e-03 | 30 | 42 | 2 | M27216 | |
| Pubmed | 3.15e-09 | 153 | 52 | 7 | 25037231 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA PDLIM7 PLEKHG3 PIN1 SRC CSTF2 NUP214 COIL THOC2 FUBP3 ARCN1 DDX6 | 2.78e-08 | 1024 | 52 | 12 | 24711643 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | HOXA6 SOX4 MSX1 NFATC4 NFIX GATAD1 EVX1 DLX1 ZFPM1 NR2F1 EBF4 | 8.22e-08 | 908 | 52 | 11 | 19274049 |
| Pubmed | 1.15e-07 | 549 | 52 | 9 | 38280479 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.46e-07 | 565 | 52 | 9 | 25468996 | |
| Pubmed | 7.29e-07 | 210 | 52 | 6 | 16537572 | ||
| Pubmed | Molecular markers of cardiac endocardial cushion development. | 8.92e-07 | 13 | 52 | 3 | 14648841 | |
| Pubmed | 8.95e-07 | 49 | 52 | 4 | 31762063 | ||
| Pubmed | SOX4 RBM12 UBAP2 NFATC4 NFIX GATAD1 CSTF2 TFIP11 NUP214 TAF10 FUBP3 CNOT3 | 9.92e-07 | 1429 | 52 | 12 | 35140242 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FLNA RBM12 UBAP2 EIF4B TFIP11 NUP214 COIL GPRIN1 THOC2 ARCN1 | 1.06e-06 | 934 | 52 | 10 | 33916271 |
| Pubmed | 1.13e-06 | 14 | 52 | 3 | 12878203 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.28e-06 | 954 | 52 | 10 | 36373674 | |
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 1.33e-06 | 54 | 52 | 4 | 25631074 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.40e-06 | 544 | 52 | 8 | 28473536 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.84e-06 | 135 | 52 | 5 | 28675934 | |
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 1.97e-06 | 137 | 52 | 5 | 37039823 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.00e-06 | 774 | 52 | 9 | 15302935 | |
| Pubmed | Mutation of murine Sox4 untranslated regions results in partially penetrant perinatal lethality. | 2.19e-06 | 2 | 52 | 2 | 25189881 | |
| Pubmed | RNase L interacts with Filamin A to regulate actin dynamics and barrier function for viral entry. | 2.19e-06 | 2 | 52 | 2 | 25352621 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 2.32e-06 | 62 | 52 | 4 | 28344315 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 4.57e-06 | 857 | 52 | 9 | 25609649 | |
| Pubmed | A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. | 4.76e-06 | 22 | 52 | 3 | 10021340 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 5.51e-06 | 877 | 52 | 9 | 20211142 | |
| Pubmed | COL4A6 is dispensable for autosomal recessive Alport syndrome. | 6.57e-06 | 3 | 52 | 2 | 27377778 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 23597509 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 6.98e-06 | 1155 | 52 | 10 | 20360068 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 8.95e-06 | 497 | 52 | 7 | 36774506 | |
| Pubmed | 9.98e-06 | 711 | 52 | 8 | 33022573 | ||
| Pubmed | 1.12e-05 | 29 | 52 | 3 | 30846445 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 8101484 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 32945508 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NFIX GATAD1 CSTF2 TFIP11 NUP214 TAF10 COIL THOC2 FUBP3 NR2F1 | 1.87e-05 | 1294 | 52 | 10 | 30804502 |
| Pubmed | 1.97e-05 | 220 | 52 | 5 | 24550385 | ||
| Pubmed | 2.05e-05 | 107 | 52 | 4 | 30995489 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 9753686 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA SETD1B PDLIM7 PLEKHG3 PIN1 TFIP11 NUP214 FUBP3 ARCN1 DDX6 | 2.74e-05 | 1353 | 52 | 10 | 29467282 |
| Pubmed | Transcriptional network orchestrating regional patterning of cortical progenitors. | 2.77e-05 | 39 | 52 | 3 | 34921112 | |
| Pubmed | 3.26e-05 | 608 | 52 | 7 | 16713569 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 3.28e-05 | 6 | 52 | 2 | 9506531 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 3.28e-05 | 6 | 52 | 2 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 3.28e-05 | 6 | 52 | 2 | 6811420 | |
| Pubmed | Variation of tooth number in mammalian dentition: connecting genetics, development, and evolution. | 3.28e-05 | 6 | 52 | 2 | 12752768 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 3.28e-05 | 6 | 52 | 2 | 6389236 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 3.28e-05 | 6 | 52 | 2 | 10534397 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 9000753 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 3.28e-05 | 6 | 52 | 2 | 9673377 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 11732842 | ||
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 15743757 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 3.28e-05 | 6 | 52 | 2 | 19275937 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 6988303 | ||
| Pubmed | TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1. | 3.73e-05 | 43 | 52 | 3 | 31992359 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.07e-05 | 256 | 52 | 5 | 33397691 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.34e-05 | 430 | 52 | 6 | 35044719 | |
| Pubmed | 4.35e-05 | 1139 | 52 | 9 | 36417873 | ||
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 4.58e-05 | 7 | 52 | 2 | 8006028 | |
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 10416788 | ||
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 1724753 | ||
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 17418794 | ||
| Pubmed | 5.07e-05 | 652 | 52 | 7 | 31180492 | ||
| Pubmed | Roles for Msx and Dlx homeoproteins in vertebrate development. | 6.10e-05 | 8 | 52 | 2 | 10773441 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 3997552 | ||
| Pubmed | Type IV collagen α6 chain is a regulator of keratin 10 in keratinization of oral mucosal epithelium. | 6.10e-05 | 8 | 52 | 2 | 29422532 | |
| Pubmed | Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. | 6.10e-05 | 8 | 52 | 2 | 18562676 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 1377218 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 10382266 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 6.10e-05 | 8 | 52 | 2 | 10970885 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 6.34e-05 | 922 | 52 | 8 | 27609421 | |
| Pubmed | 7.41e-05 | 54 | 52 | 3 | 35391932 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 7.70e-05 | 477 | 52 | 6 | 31300519 | |
| Pubmed | Genetic aspects of embryonic eye development in vertebrates. | 7.84e-05 | 9 | 52 | 2 | 8631154 | |
| Pubmed | Role of Dlx-1 and Dlx-2 genes in patterning of the murine dentition. | 7.84e-05 | 9 | 52 | 2 | 9428417 | |
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 9878537 | ||
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 12101409 | ||
| Pubmed | 8.26e-05 | 56 | 52 | 3 | 19299420 | ||
| Pubmed | 8.72e-05 | 1247 | 52 | 9 | 27684187 | ||
| Pubmed | Dlx and other homeobox genes in the morphological development of the dentition. | 9.79e-05 | 10 | 52 | 2 | 7554933 | |
| Pubmed | 9.79e-05 | 10 | 52 | 2 | 9136074 | ||
| Pubmed | Distal-less and other homeobox genes in the development of the dentition. | 9.79e-05 | 10 | 52 | 2 | 7964557 | |
| Pubmed | 9.79e-05 | 10 | 52 | 2 | 7915533 | ||
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 1.03e-04 | 162 | 52 | 4 | 31363146 | |
| Pubmed | 1.16e-04 | 167 | 52 | 4 | 22159717 | ||
| Pubmed | 1.20e-04 | 11 | 52 | 2 | 20824138 | ||
| Pubmed | 1.20e-04 | 11 | 52 | 2 | 14998921 | ||
| Pubmed | 1.20e-04 | 11 | 52 | 2 | 12358782 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 1.20e-04 | 11 | 52 | 2 | 7500359 | |
| Pubmed | Msx1 controls inductive signaling in mammalian tooth morphogenesis. | 1.20e-04 | 11 | 52 | 2 | 8898217 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.33e-04 | 1318 | 52 | 9 | 30463901 | |
| Pubmed | 1.39e-04 | 175 | 52 | 4 | 28071719 | ||
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 15140878 | ||
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 15306564 | ||
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 30013108 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.43e-04 | 12 | 52 | 2 | 12180907 | |
| Pubmed | Orientation of the Hoxa complex and placement of the Hd locus distal to Hoxa2 on mouse chromosome 6. | 1.43e-04 | 12 | 52 | 2 | 8833244 | |
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 1.43e-04 | 12 | 52 | 2 | 15837576 | |
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 16024816 | ||
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 1.54e-04 | 69 | 52 | 3 | 28481362 | |
| Pubmed | SOXC proteins amplify canonical WNT signaling to secure nonchondrocytic fates in skeletogenesis. | 1.69e-04 | 13 | 52 | 2 | 25452386 | |
| Interaction | R3HDM2 interactions | 9.79e-07 | 129 | 52 | 6 | int:R3HDM2 | |
| Interaction | G3BP2 interactions | 6.29e-06 | 518 | 52 | 9 | int:G3BP2 | |
| Interaction | CNOT2 interactions | 6.34e-06 | 178 | 52 | 6 | int:CNOT2 | |
| Interaction | PABPC1 interactions | 1.00e-05 | 699 | 52 | 10 | int:PABPC1 | |
| Interaction | CNOT3 interactions | 1.50e-05 | 207 | 52 | 6 | int:CNOT3 | |
| Interaction | SMG7 interactions | 1.69e-05 | 319 | 52 | 7 | int:SMG7 | |
| Interaction | MEX3B interactions | 2.23e-05 | 222 | 52 | 6 | int:MEX3B | |
| Interaction | DAZL interactions | 3.56e-05 | 145 | 52 | 5 | int:DAZL | |
| Interaction | CPEB1 interactions | 3.68e-05 | 146 | 52 | 5 | int:CPEB1 | |
| Interaction | ZBTB10 interactions | 4.32e-05 | 151 | 52 | 5 | int:ZBTB10 | |
| Interaction | G3BP1 interactions | 4.60e-05 | 835 | 52 | 10 | int:G3BP1 | |
| Interaction | AGO3 interactions | 4.60e-05 | 153 | 52 | 5 | int:AGO3 | |
| Interaction | CPEB4 interactions | 5.05e-05 | 156 | 52 | 5 | int:CPEB4 | |
| Interaction | CFL1 interactions | 5.52e-05 | 384 | 52 | 7 | int:CFL1 | |
| Interaction | USP4 interactions | 1.04e-04 | 293 | 52 | 6 | int:USP4 | |
| Interaction | PLOD3 interactions | 1.08e-04 | 183 | 52 | 5 | int:PLOD3 | |
| Interaction | FXR2 interactions | 1.12e-04 | 430 | 52 | 7 | int:FXR2 | |
| Interaction | FOXP3 interactions | 1.15e-04 | 432 | 52 | 7 | int:FOXP3 | |
| Interaction | CDH1 interactions | 1.37e-04 | 768 | 52 | 9 | int:CDH1 | |
| Interaction | BCL11A interactions | 1.39e-04 | 102 | 52 | 4 | int:BCL11A | |
| Interaction | ATG16L1 interactions | FLNA PDLIM7 PLEKHG3 PIN1 EIF4B CSTF2 TAF10 COIL CNOT3 ANKRD26P1 ITPR1 | 1.50e-04 | 1161 | 52 | 11 | int:ATG16L1 |
| Interaction | NAA40 interactions | FLNA RBM12 UBAP2 EIF4B TFIP11 NUP214 COIL GPRIN1 THOC2 ARCN1 | 1.70e-04 | 978 | 52 | 10 | int:NAA40 |
| Interaction | LSM14B interactions | 1.79e-04 | 109 | 52 | 4 | int:LSM14B | |
| Interaction | DCN interactions | 1.86e-04 | 43 | 52 | 3 | int:DCN | |
| Interaction | RBMS1 interactions | 1.91e-04 | 207 | 52 | 5 | int:RBMS1 | |
| Interaction | AGO2 interactions | 1.99e-04 | 472 | 52 | 7 | int:AGO2 | |
| Interaction | SMC5 interactions | 2.04e-04 | 1000 | 52 | 10 | int:SMC5 | |
| Interaction | ZC3H7A interactions | 2.28e-04 | 215 | 52 | 5 | int:ZC3H7A | |
| Interaction | C1QTNF1 interactions | 2.42e-04 | 47 | 52 | 3 | int:C1QTNF1 | |
| Interaction | AGO4 interactions | 2.43e-04 | 118 | 52 | 4 | int:AGO4 | |
| Interaction | SAMD4B interactions | 2.76e-04 | 122 | 52 | 4 | int:SAMD4B | |
| Interaction | RBBP8 interactions | 2.76e-04 | 122 | 52 | 4 | int:RBBP8 | |
| Interaction | ATXN1 interactions | 2.78e-04 | 1039 | 52 | 10 | int:ATXN1 | |
| Interaction | FN1 interactions | 2.86e-04 | 848 | 52 | 9 | int:FN1 | |
| Interaction | HDLBP interactions | 3.04e-04 | 855 | 52 | 9 | int:HDLBP | |
| Interaction | CNOT9 interactions | 3.18e-04 | 231 | 52 | 5 | int:CNOT9 | |
| Interaction | MARF1 interactions | 3.32e-04 | 128 | 52 | 4 | int:MARF1 | |
| Interaction | KMT2B interactions | 3.52e-04 | 130 | 52 | 4 | int:KMT2B | |
| Interaction | LARP4B interactions | 3.78e-04 | 240 | 52 | 5 | int:LARP4B | |
| Interaction | TLE3 interactions | 4.00e-04 | 376 | 52 | 6 | int:TLE3 | |
| Interaction | YTHDF3 interactions | 4.24e-04 | 246 | 52 | 5 | int:YTHDF3 | |
| Interaction | MCRIP1 interactions | 4.30e-04 | 57 | 52 | 3 | int:MCRIP1 | |
| Interaction | FBXO22 interactions | 4.49e-04 | 540 | 52 | 7 | int:FBXO22 | |
| Interaction | PRRC2A interactions | 4.79e-04 | 389 | 52 | 6 | int:PRRC2A | |
| Interaction | CNOT10 interactions | 4.79e-04 | 141 | 52 | 4 | int:CNOT10 | |
| GeneFamily | Collagens | 6.95e-10 | 46 | 40 | 6 | 490 | |
| GeneFamily | RNA binding motif containing | 1.23e-03 | 213 | 40 | 4 | 725 | |
| GeneFamily | HOXL subclass homeoboxes | 5.90e-03 | 52 | 40 | 2 | 518 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 9.64e-03 | 67 | 40 | 2 | 519 | |
| Coexpression | NABA_COLLAGENS | 3.02e-10 | 44 | 52 | 6 | M3005 | |
| Coexpression | NABA_COLLAGENS | 2.29e-08 | 43 | 52 | 5 | MM17060 | |
| Coexpression | NABA_CORE_MATRISOME | 1.16e-06 | 275 | 52 | 7 | M5884 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | SOX4 COL4A6 COL6A2 RBM12 RNASEL PDLIM7 TMCC2 THOC2 MTMR10 MEX3B USP6NL EBF4 | 1.25e-06 | 1102 | 52 | 12 | M2369 |
| Coexpression | DESCARTES_FETAL_LUNG_MEGAKARYOCYTES | 1.51e-06 | 180 | 52 | 6 | M40239 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | SOX4 COL4A6 COL6A2 RBM12 RNASEL PDLIM7 TMCC2 THOC2 MTMR10 MEX3B USP6NL EBF4 | 1.54e-06 | 1124 | 52 | 12 | MM1070 |
| Coexpression | NABA_CORE_MATRISOME | 1.55e-05 | 270 | 52 | 6 | MM17057 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 2.96e-05 | 303 | 52 | 6 | M39040 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 6.91e-05 | 40 | 52 | 3 | M5887 | |
| Coexpression | SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN | 9.85e-05 | 45 | 52 | 3 | M1369 | |
| Coexpression | SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN | 9.85e-05 | 45 | 52 | 3 | MM576 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-06 | 167 | 52 | 5 | 5c82d801e3b7d7c6c967a73b94b2ee2a8da1fd6e | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.73e-06 | 172 | 52 | 5 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.75e-06 | 189 | 52 | 5 | 8e6b6025f5554672e26a5d19fe365acb4333789c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-06 | 190 | 52 | 5 | c01a8bfb9fbc0e6f37d7e9be25512eda63acabbc | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.82e-06 | 190 | 52 | 5 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-06 | 191 | 52 | 5 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.97e-06 | 192 | 52 | 5 | f053b89bfd6048c227667ff01c38df7c51d8a496 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-06 | 195 | 52 | 5 | 717e6a66bad50e711442d71360b540789646b334 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-06 | 195 | 52 | 5 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-06 | 195 | 52 | 5 | 10774b5ce17d4edd23dbf4709b11cc87cc2b87be | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-06 | 196 | 52 | 5 | cbfe01ba8071864e19b37028236ae35789f630fe | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-06 | 196 | 52 | 5 | 5146976881d79642ebe5dcbcf89e0252713a9ef2 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.28e-06 | 196 | 52 | 5 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-06 | 196 | 52 | 5 | ebac1d6af7a5732707d82d01285c086b19d8ae62 | |
| ToppCell | P07-Mesenchymal-myocytic_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.36e-06 | 197 | 52 | 5 | 378299fe2ec6ed2fc858febb78ff1ac0898e457d | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Airway_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.36e-06 | 197 | 52 | 5 | 233caeee200ca905900226f85426e084caf290fb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.36e-06 | 197 | 52 | 5 | 398a66c06df63567b176ab2cc85e27837e94d0d9 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.36e-06 | 197 | 52 | 5 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-06 | 198 | 52 | 5 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-06 | 198 | 52 | 5 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.62e-06 | 200 | 52 | 5 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D2|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-05 | 145 | 52 | 4 | 3a34c25ff77cd33fdca84742097cc7484066ebc4 | |
| ToppCell | Lung_Parenchyma-Control-Hematopoietic|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.99e-05 | 152 | 52 | 4 | 71d5061aee7f744b2db3c3892d15c6919d07c0be | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Erythrocytes|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.99e-05 | 152 | 52 | 4 | bf07aafe2f36eda3a9cda93083ca7a081498e36e | |
| ToppCell | Lung_Parenchyma-Control-Hematopoietic-RBC-RBC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-05 | 152 | 52 | 4 | 27f25c1e22a81fbdd6c39ca47eeb310939211362 | |
| ToppCell | Lung_Parenchyma-Control-Hematopoietic-RBC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.99e-05 | 152 | 52 | 4 | df87b8333e3f54fab0d8b1e8690f1a36bcb7e9e3 | |
| ToppCell | Lung_Parenchyma-Control-Hematopoietic-RBC-RBC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.99e-05 | 152 | 52 | 4 | 98cdcf18daeb728974ab133b365b7352b08558a8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.39e-05 | 157 | 52 | 4 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.48e-05 | 158 | 52 | 4 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.65e-05 | 160 | 52 | 4 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-hematologic-erythrocytic-erythrocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.83e-05 | 162 | 52 | 4 | 25a11e4c6304324310b33a33331ebc812d045d4a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-GABAergic_neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 4.02e-05 | 164 | 52 | 4 | 4d7b2d0980fb4f47721fa2891151e2bd892ccb91 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.21e-05 | 166 | 52 | 4 | f416d8a322f086c769659a9fab6b460a2d546ab1 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-ILC3|Lung / Manually curated celltypes from each tissue | 4.31e-05 | 167 | 52 | 4 | 0614d077b47a87f726068615548d0b0a216627be | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-hematopoietic_progenitor-erythroid_progenitor_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.62e-05 | 170 | 52 | 4 | 74bb46826141bd1e80b4ce16e6bbfc770bd427d3 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-hematopoietic_progenitor|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.62e-05 | 170 | 52 | 4 | 6592ebe204b43b81c6b6da99e05da72c0983b3fa | |
| ToppCell | mild-Others-CD34+_GATA2+_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.84e-05 | 172 | 52 | 4 | 379f6f271e653d5e404851e51a189bd582bb0f43 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.95e-05 | 173 | 52 | 4 | ecbf7167d4bec685e3460d826318544946f5f5c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.95e-05 | 173 | 52 | 4 | b8dc978c52de64afba21ff6cb32e79f07167448e | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-05 | 176 | 52 | 4 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.41e-05 | 177 | 52 | 4 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.41e-05 | 177 | 52 | 4 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.53e-05 | 178 | 52 | 4 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.53e-05 | 178 | 52 | 4 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.53e-05 | 178 | 52 | 4 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC-HSPC|COVID-19_Mild / Disease group, lineage and cell class | 5.65e-05 | 179 | 52 | 4 | 19fcf48f5e02e4cb2b328efb4502f337e1282f72 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.65e-05 | 179 | 52 | 4 | 4bb2debfc9e9f258cd38e797ef160bd440aad6af | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.65e-05 | 179 | 52 | 4 | 2f690f933bf6b99abeb31766e0b22bdbe36c1ba0 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.65e-05 | 179 | 52 | 4 | 3e2c937369b8190fd5d5a31689d029e6e89fb5e2 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC|COVID-19_Mild / Disease group, lineage and cell class | 5.65e-05 | 179 | 52 | 4 | 50a073166e34bcfa52a62c4dafb3aef724e0fa8e | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 5.77e-05 | 180 | 52 | 4 | 237a2130a3f48595dad2417539c21e44585962b8 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.90e-05 | 181 | 52 | 4 | e7f7b519c2a01c15f26df11ec9b434c0d1630c7a | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.90e-05 | 181 | 52 | 4 | 54a19cf6a3b752e2391feb8b316bebee0e602d17 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.90e-05 | 181 | 52 | 4 | 5b84625b1d3737708001b64f6da9360330d39a27 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.90e-05 | 181 | 52 | 4 | 0c52dd82e6b3dce3d6bb5c13501bf8383f7121e4 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.16e-05 | 183 | 52 | 4 | ffa831f67ed005f05d1b80ebc707e046fc08e22f | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.29e-05 | 184 | 52 | 4 | 235890e8b424f4386b6ea52d173d20a00898df73 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 6.56e-05 | 186 | 52 | 4 | a5c0bd4f6a7542f67d478dcdc0645ae6d927a395 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue | 6.56e-05 | 186 | 52 | 4 | 5624b1fc7eab9f505588fcc86a24d14f8bcbfef7 | |
| ToppCell | Control-Fibroblasts-Pathological_FB|Control / group, cell type (main and fine annotations) | 6.69e-05 | 187 | 52 | 4 | b7280b8baa0fba9c2b4bff660c240ed96f6ff9b7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.69e-05 | 187 | 52 | 4 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.69e-05 | 187 | 52 | 4 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-05 | 188 | 52 | 4 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 6.83e-05 | 188 | 52 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.83e-05 | 188 | 52 | 4 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 6.83e-05 | 188 | 52 | 4 | ab1384e6f71053946368502282aeebf1ba92d33e | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.98e-05 | 189 | 52 | 4 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-05 | 189 | 52 | 4 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | 10x5'-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue | 6.98e-05 | 189 | 52 | 4 | 9837dca502c9a7f42efb0bc74f3e88e7461e7dc8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-05 | 189 | 52 | 4 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 190 | 52 | 4 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.12e-05 | 190 | 52 | 4 | 60bb6aaea9691d07295f61c14d1650f5041a0f9c | |
| ToppCell | COVID_vent-Lymphocytic-B_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.12e-05 | 190 | 52 | 4 | 40b5e9e8f8fd8d84cb5b43e67b49267082348e9f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 190 | 52 | 4 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | COVID_vent-Lymphocytic-B_cell-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.12e-05 | 190 | 52 | 4 | a37a32dc1b931562a6660074e19d5598efc65284 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 190 | 52 | 4 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 190 | 52 | 4 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Control-Lymphoid_B-B_intermediate|Control / Disease group, lineage and cell class | 7.27e-05 | 191 | 52 | 4 | 0082181dbc39c7c4fd3aa34c3ed61439548e844b | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.27e-05 | 191 | 52 | 4 | b7d17d3ba488378b30f3732f8109f4a7c1673e61 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.27e-05 | 191 | 52 | 4 | 2453064c39b359088d43d52792bf829f83442c82 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.27e-05 | 191 | 52 | 4 | 5a9a592875fbd0b1429b48db29a760fdc9c2c856 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 191 | 52 | 4 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | COVID-19_Severe-B_intermediate|World / disease group, cell group and cell class | 7.27e-05 | 191 | 52 | 4 | f226fd69a26124ba98e4544f550b89a08e6a3708 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-05 | 192 | 52 | 4 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| ToppCell | healthy_donor-Lymphocytic-B_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.41e-05 | 192 | 52 | 4 | 7d9e5772b6e531b50ed4e4d6304ef11235f27f37 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.41e-05 | 192 | 52 | 4 | f9f64ad7bab1433e9a45adb7db7f43ce3f591b47 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.41e-05 | 192 | 52 | 4 | 4884fd8ffa6fd6c30d7ac6bf447456b3397eabc5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.41e-05 | 192 | 52 | 4 | 89b8ebdc285ed3c0f807fd1157271130d37dfa41 | |
| ToppCell | Healthy/Control-B_intermediate|World / Disease group and Cell class | 7.41e-05 | 192 | 52 | 4 | 2266aa695955f5d885708e6bc0d5a8827c306223 | |
| ToppCell | healthy_donor-Lymphocytic-B_cell-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.41e-05 | 192 | 52 | 4 | 975312f9d6cede4d4f5b737e481e5c73accc8c50 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.56e-05 | 193 | 52 | 4 | 469a7f1c2ff7137cc5a064464456911f67f92e70 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.56e-05 | 193 | 52 | 4 | 323d1f3f4fbeb93ba857fc135d8aa0b897f98ac5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.56e-05 | 193 | 52 | 4 | 8f1d6024ef092923321e6efd441b8d476db70aed | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.56e-05 | 193 | 52 | 4 | 32d139f922cd19adc1cc1e0e9a828115be9945d6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.56e-05 | 193 | 52 | 4 | 6e6c5ae39ea880ba809019a7d39f50e4e02007ed | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.56e-05 | 193 | 52 | 4 | c04ac5884be4245b75d211046f04d76ae0cfb998 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.56e-05 | 193 | 52 | 4 | 749faa5c592ee354733f5a7363a4277ef3462b93 | |
| Computational | Ovary genes. | 5.29e-06 | 368 | 30 | 8 | MODULE_1 | |
| Drug | ticlopidine | 3.57e-09 | 103 | 52 | 7 | CID000005472 | |
| Drug | AC1LAKND | 5.87e-09 | 62 | 52 | 6 | CID000470146 | |
| Drug | BAPN | 1.35e-08 | 71 | 52 | 6 | CID000001647 | |
| Drug | GK-101 | 1.82e-08 | 36 | 52 | 5 | CID000161853 | |
| Drug | AC1NMZ1B | 1.88e-08 | 75 | 52 | 6 | CID005034185 | |
| Drug | PCR 4099 | 2.89e-08 | 139 | 52 | 7 | CID000002806 | |
| Drug | halofuginone lactate | 4.02e-08 | 85 | 52 | 6 | CID000062891 | |
| Drug | 4-hydroxyproline | 6.06e-08 | 91 | 52 | 6 | CID000000825 | |
| Drug | Madecassol | 6.51e-08 | 46 | 52 | 5 | CID000108062 | |
| Drug | d-indobufen | 1.00e-07 | 50 | 52 | 5 | CID000044562 | |
| Drug | ridogrel | 1.22e-07 | 52 | 52 | 5 | CID005362391 | |
| Drug | NSC49633 | 1.35e-07 | 53 | 52 | 5 | CID000023340 | |
| Drug | hyaluronan | 1.38e-07 | 263 | 52 | 8 | CID000024759 | |
| Drug | hydroxylysine | 1.78e-07 | 109 | 52 | 6 | CID000001029 | |
| Drug | PPACK | 2.21e-07 | 113 | 52 | 6 | CID003036757 | |
| Drug | Tranilast sodium | 2.45e-07 | 115 | 52 | 6 | CID000005527 | |
| Drug | DMSe | 5.54e-07 | 132 | 52 | 6 | CID000020796 | |
| Drug | malotilate | 5.93e-07 | 71 | 52 | 5 | CID000004006 | |
| Drug | pirfenidone | 7.20e-07 | 138 | 52 | 6 | CID000040632 | |
| Drug | DL-penicillamine | 7.51e-07 | 139 | 52 | 6 | CID000004727 | |
| Drug | strontium ranelate | 8.90e-07 | 77 | 52 | 5 | CID006918182 | |
| Drug | AC1Q6PCP | 8.91e-07 | 230 | 52 | 7 | CID000005267 | |
| Drug | khellin | 2.51e-06 | 171 | 52 | 6 | CID000003828 | |
| Drug | AC1L1DD6 | 3.27e-06 | 179 | 52 | 6 | CID000002299 | |
| Drug | AC1L1C2F | 5.21e-06 | 110 | 52 | 5 | CID000001711 | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; MCF7; HT_HG-U133A | 5.52e-06 | 196 | 52 | 6 | 6101_UP | |
| Drug | sulindac sulfide; Down 200; 50uM; MCF7; HG-U133A | 5.68e-06 | 197 | 52 | 6 | 308_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 6.02e-06 | 199 | 52 | 6 | 3606_UP | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 1uM; MCF7; HT_HG-U133A | 6.02e-06 | 199 | 52 | 6 | 3633_UP | |
| Drug | AC1L9732 | 6.21e-06 | 114 | 52 | 5 | CID000439300 | |
| Drug | Y-27632 | 6.97e-06 | 444 | 52 | 8 | CID000005711 | |
| Drug | AC1L18QD | 8.73e-06 | 325 | 52 | 7 | CID000000213 | |
| Drug | Selara | 9.73e-06 | 125 | 52 | 5 | CID000150310 | |
| Drug | AC1L1KMJ | 1.16e-05 | 476 | 52 | 8 | CID000030956 | |
| Drug | candesartan cilexetil | 2.00e-05 | 145 | 52 | 5 | CID000002540 | |
| Drug | L-3,4-dehydroproline | 2.34e-05 | 73 | 52 | 4 | CID000094284 | |
| Drug | colchine | 2.52e-05 | 383 | 52 | 7 | CID000002833 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 3.40e-05 | 162 | 52 | 5 | CID000072363 | |
| Drug | silibinin | 4.58e-05 | 285 | 52 | 6 | CID000005213 | |
| Drug | cyclophorine | 4.94e-05 | 426 | 52 | 7 | CID000002909 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 7.08e-05 | 189 | 52 | 5 | CID000001413 | |
| Drug | ionomycin calcium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 7.08e-05 | 189 | 52 | 5 | 882_UP | |
| Drug | foscarnet | 7.26e-05 | 190 | 52 | 5 | CID000003414 | |
| Drug | valinomycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.44e-05 | 191 | 52 | 5 | 5957_DN | |
| Drug | (2s,5s)-5-Carboxymethylproline | 7.83e-05 | 314 | 52 | 6 | CID000447989 | |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; HL60; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 2425_UP | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 3634_UP | |
| Drug | Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 7470_DN | |
| Drug | Alcuronium chloride [15180-03-7]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 4409_UP | |
| Drug | Ajmaline [4360-12-7]; Up 200; 12.2uM; HL60; HG-U133A | 8.61e-05 | 197 | 52 | 5 | 1749_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; PC3; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 2119_UP | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 3304_UP | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 5285_DN | |
| Drug | Pimozide [2062-78-4]; Down 200; 8.6uM; PC3; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 7132_DN | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; PC3; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 7301_DN | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 4825_DN | |
| Drug | Succinylsulfathiazole [116-43-8]; Up 200; 11.2uM; PC3; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 4265_UP | |
| Drug | Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 7018_UP | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 6503_UP | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 2124_UP | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 6508_UP | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 7307_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 4441_DN | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 3636_UP | |
| Drug | Propantheline bromide [50-34-0]; Up 200; 9uM; HL60; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 3013_UP | |
| Drug | sulindac sulfone; Down 200; 50uM; MCF7; HG-U133A | 9.03e-05 | 199 | 52 | 5 | 309_DN | |
| Drug | Ketotifen fumarate [34580-14-8]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 3200_UP | |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; PC3; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 4649_DN | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 3603_UP | |
| Drug | Gabapentin [60142-96-3]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 9.25e-05 | 200 | 52 | 5 | 7229_DN | |
| Drug | Halon 1301 | 1.82e-04 | 9 | 52 | 2 | CID000006384 | |
| Drug | AC1L1GTT | 1.89e-04 | 233 | 52 | 5 | CID000003837 | |
| Drug | losartan | 2.15e-04 | 378 | 52 | 6 | CID000003961 | |
| Drug | prostacyclin sodium salt | 2.62e-04 | 250 | 52 | 5 | CID000000159 | |
| Drug | aspirin | 2.78e-04 | 563 | 52 | 7 | CID000002244 | |
| Drug | Win 55212-2 | 3.17e-04 | 58 | 52 | 3 | ctd:C070417 | |
| Drug | chondroitin sulfate | 3.46e-04 | 413 | 52 | 6 | CID000024766 | |
| Drug | Tygon | 3.93e-04 | 13 | 52 | 2 | CID000061927 | |
| Disease | myopathy (implicated_via_orthology) | 1.14e-06 | 48 | 48 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | asthma (implicated_via_orthology) | 2.55e-05 | 35 | 48 | 3 | DOID:2841 (implicated_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 1.69e-04 | 12 | 48 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | 3.10e-04 | 1074 | 48 | 8 | C0006142 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 4.35e-04 | 19 | 48 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Multiple Epiphyseal Dysplasia | 4.83e-04 | 20 | 48 | 2 | C0026760 | |
| Disease | Epileptic encephalopathy | 1.09e-03 | 30 | 48 | 2 | C0543888 | |
| Disease | brain ischemia (implicated_via_orthology) | 1.49e-03 | 35 | 48 | 2 | DOID:2316 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KPTGGPGGGGTQTQQ | 26 | P26196 | |
| GIQGPTGPQGFTGST | 56 | Q14031 | |
| KGSQGSAGSNGFPGP | 971 | Q14031 | |
| PKGTQGPNGTSGVQG | 476 | Q14050 | |
| GVPGCSGSKGEQGFP | 121 | Q01955 | |
| AAGLKGSPGSPGNTG | 506 | Q01955 | |
| GSPNGGSETPKSNGG | 151 | P49640 | |
| GFGGQKGQGPSCSFT | 6 | Q6NSI1 | |
| SSGKGSGGNAGSYIP | 221 | P56177 | |
| GASIQGGSQPGGFSP | 511 | P33240 | |
| GGVAPGSGNNSGGPS | 481 | O75175 | |
| GFGGGPNNLSGPSGF | 771 | Q9NTZ6 | |
| TAGDKGQGPPGSGQS | 66 | P10589 | |
| TGQPNGSGQGKVPGS | 416 | Q14938 | |
| SGASPSGSGKQRGPG | 86 | P31267 | |
| TSFGNGPLSAGGPGK | 1766 | Q14643 | |
| GGNGAGGGSSQKTPL | 206 | Q9NXD2 | |
| RPSGNSSSGGKNGQG | 36 | Q13526 | |
| GGTNLGAPGAFGQSP | 426 | Q96I24 | |
| GAGGAQTGLFPGAPK | 561 | Q8IX07 | |
| GSNGGGQAPGASPSV | 371 | P38432 | |
| FGQSSPNTGGGLFGQ | 1786 | P35658 | |
| SNAPAFGQSPGFGQG | 1801 | P35658 | |
| AGGVPGGGSNNGKTP | 266 | Q9NR12 | |
| GNPFGGSETNGGANP | 366 | Q9BY11 | |
| TPPQSNGGGGGKQSK | 71 | Q8WUU5 | |
| PSPGSQQSGYGGGLG | 466 | Q9BQW3 | |
| PGFPGQKGEQGFEGS | 321 | Q14993 | |
| KAFGPGLQGGSAGSP | 1071 | P21333 | |
| GSKGYQGNSGAPGSP | 391 | P12110 | |
| QGNSGAPGSPGVKGA | 396 | P12110 | |
| GSNGSPGQPGTPGSK | 641 | Q96P44 | |
| GPGSTGNRNPGSSGT | 301 | P02671 | |
| SGKNGPVSSGTGAPG | 326 | Q7Z2K8 | |
| QGKKAPGFGGFGSSA | 176 | P48444 | |
| GNSSGSGCKSPLGGF | 496 | Q96NU0 | |
| PKGQTGNSSRGPGDG | 536 | P23588 | |
| FPGGGASAPSNANLG | 411 | Q6ZN04 | |
| GGGASGGGANSKPAQ | 181 | Q06945 | |
| GAGGGAFPASQTPSK | 26 | P12931 | |
| NKASPAGTAGGPGAG | 41 | Q12962 | |
| SNSGAGPGGALGSPK | 491 | O75069 | |
| QGGGAFFSPSPGSSS | 161 | Q14934 | |
| FGKPAGGGAGQAPSA | 21 | P28360 | |
| GSPGKGPGQGQANGF | 826 | A1L390 | |
| SPNKPQCDGAGGASG | 721 | Q05823 | |
| AVGGTGGSSGPPFKA | 356 | Q9UPS6 | |
| GGSKGQLPSGSSQFP | 26 | Q02383 | |
| GGASGGPQGPSDKGF | 346 | Q8N8E2 | |
| GSSQAPNKSAGSGPG | 986 | Q5T6F2 | |
| GAGGYSGNSGSPKNG | 706 | Q92738 | |
| QNGPGGGPSSSSIGS | 1201 | Q8NI27 | |
| FNGAPSSSGGFSGGP | 741 | Q12816 | |
| KQSAGPNSPTGGGGG | 46 | A7E2V4 | |
| FPGGNKGGGTSCGPA | 286 | Q86YW5 | |
| TGGNFKPSQKGFAGG | 121 | Q9UBB9 |